Court Rules in Favor of Roche Diagnostics in Patent Dispute with Enzo Biochem.
PLEASANTON, Calif. -- Roche Diagnostics Roche Diagnostics Division is a subsidiary of Hoffmann-La Roche which manufactures equipment and reagents for research and medical diagnostic applications. Internally, it is organized into six major business areas: Roche Applied Science, Roche Centralized Diagnostics, Roche today announced that a district judge in New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of has ruled in favor of Roche Diagnostics on important aspects of patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. allegations brought by Enzo Biochem.
The Court adopted virtually all of the interpretations proposed by Roche Diagnostics and its co-parties relating to relating to relate prep → concernant
relating to relate prep → bezüglich +gen, mit Bezug auf +acc seven Enzo patents covered by the order. Judge Sprizzo's ruling followed a week long hearing in July 2005 and extensive legal briefs Legal Briefs is an interactive television program aired on CablePulse24 and CourtTV Canada, hosted by Lorne Honickman, a lawyer and journalist, as he discusses the ins & outs of the Canadian legal system and provides free legal advice. by the parties.
"This order will allow us to request a further ruling from the Court, declaring that Roche does not infringe on this patent," said Melinda Griffith, Senior Vice President and General Counsel of Roche Molecular Diagnostics, a business unit of Roche Diagnostics. "We look forward to the successful conclusion of this litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.
When a person begins a civil lawsuit, the person enters into a process called litigation. ."
The litigation, first filed in 2002, concerns products and techniques for detecting genetic information in biological samples, such as blood.
Among its allegations, Enzo contends that Roche's AmpliChip CYP450 Test AmpliChip CYP450 Test is a clinical test from Roche. The test aims to find the specific gene types (a genotype) of the patient that will determine how he or she metabolizes certain medicines, therefore guides the doctors to prescribe medicine for best effectiveness and least side infringes Enzo's U.S. Patent No. 4,994,373. However, Judge Sprizzo's order rejected Enzo's interpretations of both the testing format and the "soluble signal" claimed by this patent, and instead agreed with interpretations by Roche Diagnostics and its co-parties.
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression . In 2005, sales by the Pharmaceuticals Division totaled 27.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.2 billion Swiss francs. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Roche's Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. For further information, please visit our websites www.roche.com and www.roche-diagnostics.com
All trademarks used or mentioned in this release are legally protected by law.